Cargando…
Berberine stimulates lysosomal AMPK independent of PEN2 and maintains cellular AMPK activity through inhibiting the dephosphorylation regulator UHRF1
Aim: AMPK is the key regulatory kinase mediating the effect of berberine (BBR) and metformin on metabolic improvement. The present study investigated the mechanism of BBR on AMPK activation at low doses, which was different from that of metformin. Methods: Lysosomes were isolated, and AMPK activity...
Autores principales: | Ren, Gang, Ding, Yu-Wei, Wang, Lu-Lu, Jiang, Jian-Dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10151516/ https://www.ncbi.nlm.nih.gov/pubmed/37144221 http://dx.doi.org/10.3389/fphar.2023.1148611 |
Ejemplares similares
-
Berberine Improves Glucose and Lipid Metabolism in HepG2 Cells Through AMPKα1 Activation
por: Ren, Gang, et al.
Publicado: (2020) -
Low-dose metformin targets the lysosomal AMPK pathway through PEN2
por: Ma, Teng, et al.
Publicado: (2022) -
Berberine Ameliorates High Glucose-Induced Cardiomyocyte Injury via AMPK Signaling Activation to Stimulate Mitochondrial Biogenesis and Restore Autophagic Flux
por: Hang, Weijian, et al.
Publicado: (2018) -
Low-dose metformin and PEN2-dependent lysosomal AMPK activation: benefits outnumber side effects
por: Liu, Longlong, et al.
Publicado: (2022) -
Berberine Attenuated Proliferation, Invasion and Migration by Targeting the AMPK/HNF4α/WNT5A Pathway in Gastric Carcinoma
por: Hu, Qian, et al.
Publicado: (2018)